BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Ono H, Akiyama H. Therapeutic strategy for patients with pN0 gastric carcinoma. J Surg Oncol. 2006;94:212-219. [PMID: 16900514 DOI: 10.1002/jso.20601] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Yu F, Wu L, Ye F, Zhang L, Li Y. Survival after Gastrectomy in Node-Negative Gastric Cancer: A Review and Meta-Analysis of Prognostic Factors. Med Sci Monit 2015;21:1911-9. [PMID: 26134762 DOI: 10.12659/MSM.893856] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Araki I, Washio M, Yamashita K, Hosoda K, Ema A, Mieno H, Moriya H, Katada N, Kikuchi S, Watanabe M. Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer. Surg Today 2018;48:478-85. [PMID: 29256147 DOI: 10.1007/s00595-017-1611-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Araki I, Hosoda K, Yamashita K, Katada N, Sakuramoto S, Moriya H, Mieno H, Ema A, Kikuchi S, Mikami T. Prognostic impact of venous invasion in stage IB node-negative gastric cancer. Gastric Cancer. 2015;18:297-305. [PMID: 24687437 DOI: 10.1007/s10120-014-0362-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
4 Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, Bruno L, Rosa F, Marchet A, Coniglio A, Saragoni L, Veltri M, Pacelli F, Roviello F, Nitti D, Giulini SM, De Manzoni G. A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010;252:70-73. [PMID: 20562605 DOI: 10.1097/sla.0b013e3181e4585e] [Cited by in Crossref: 84] [Cited by in F6Publishing: 50] [Article Influence: 7.6] [Reference Citation Analysis]
5 Fan S, Feng M, Wang M, Guan W. Extensive small bowel metastasis and peritoneal dissemination 1 year following curative gastrectomy for T1N1 gastric cancer: A case report. Medicine (Baltimore) 2019;98:e13984. [PMID: 30702557 DOI: 10.1097/MD.0000000000013984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kunisaki C, Makino H, Kimura J, Takagawa R, Kosaka T, Ono HA, Akiyama H, Fukushima T, Nagahori Y, Takahashi M. Impact of lymphovascular invasion in patients with stage I gastric cancer. Surgery. 2010;147:204-211. [PMID: 19878963 DOI: 10.1016/j.surg.2009.08.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
7 Sun D, Gong R, Wu H. Do patients with pN0 gastric cancer benefit from prophylactic extended lymphadenectomy? Surg Oncol. 2012;21:e7-11. [PMID: 22071221 DOI: 10.1016/j.suronc.2011.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
8 Du C, Zhou Y, Cai H, Zhao G, Fu H, Shi YQ. Poor prognostic factors in patients with stage I gastric cancer according to the seventh edition TNM classification: a comparative analysis of three subgroups. J Surg Oncol. 2012;105:323-328. [PMID: 22271501 DOI: 10.1002/jso.22082] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
9 Seymour MT, Trigonis I, Finan PJ, Halstead F, Dunham R, Wilson G, Farrugia D, Chester JD, King J, Brown CB, Slevin ML, Joel SP. A feasibility, pharmacokinetic and frequency-escalation trial of intraperitoneal chemotherapy in high risk gastrointestinal tract cancer. Eur J Surg Oncol 2008;34:403-9. [PMID: 17604939 DOI: 10.1016/j.ejso.2007.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Baiocchi GL, Molfino S, Baronchelli C, Giacopuzzi S, Marrelli D, Morgagni P, Bencivenga M, Saragoni L, Vindigni C, Portolani N, Botticini M, De Manzoni G. Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series. World J Gastroenterol 2017;23:8000-7. [PMID: 29259375 DOI: 10.3748/wjg.v23.i45.8000] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yang K, Chen MX, Choi YY, Zhou ZG, Hyung WJ, Noh SH, Hu JK. The Effectiveness of Postoperative Chemotherapy on pT1bN0 and pT2N0 Gastric Cancer Patients with Risk Factors: An International Dual-Center Analysis. Yonsei Med J 2021;62:109-17. [PMID: 33527790 DOI: 10.3349/ymj.2021.62.2.109] [Reference Citation Analysis]